Atsushi Nonami

2.3k total citations
35 papers, 1.4k citations indexed

About

Atsushi Nonami is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Atsushi Nonami has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Hematology and 8 papers in Oncology. Recurrent topics in Atsushi Nonami's work include Acute Myeloid Leukemia Research (8 papers), Fibroblast Growth Factor Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Atsushi Nonami is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Fibroblast Growth Factor Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Atsushi Nonami collaborates with scholars based in Japan, United States and Germany. Atsushi Nonami's co-authors include Reiko Kato, Takaharu Taketomi, Akihiko Yoshimura, Atsuo T. Sasaki, Mika Sasaki, Kazuko Saeki, Naoaki Saito, Masamitsu Kuriyama, Koji Nagafuji and Masabumi Shibuya and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Atsushi Nonami

35 papers receiving 1.4k citations

Peers

Atsushi Nonami
Eric M. Bindels Netherlands
Janet M. Cowan United States
Shareef Nahas United States
Gregg P. Solar United States
Atsushi Nonami
Citations per year, relative to Atsushi Nonami Atsushi Nonami (= 1×) peers Liat Drucker

Countries citing papers authored by Atsushi Nonami

Since Specialization
Citations

This map shows the geographic impact of Atsushi Nonami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Nonami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Nonami more than expected).

Fields of papers citing papers by Atsushi Nonami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Nonami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Nonami. The network helps show where Atsushi Nonami may publish in the future.

Co-authorship network of co-authors of Atsushi Nonami

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Nonami. A scholar is included among the top collaborators of Atsushi Nonami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Nonami. Atsushi Nonami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikeda, Masataka, Tomomi Ide, Shouji Matsushima, et al.. (2022). Immunomodulatory Cell Therapy Using αGalCer-Pulsed Dendritic Cells Ameliorates Heart Failure in a Murine Dilated Cardiomyopathy Model. Circulation Heart Failure. 15(12). e009366–e009366. 14 indexed citations
2.
Tan, Li, Deepak Gurbani, Ellen Weisberg, et al.. (2016). Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors. Bioorganic & Medicinal Chemistry. 25(4). 1320–1328. 18 indexed citations
3.
Bhanot, Haymanti, Mamatha M. Reddy, Atsushi Nonami, et al.. (2015). Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells. Leukemia. 29(7). 1555–1563. 41 indexed citations
4.
Puente, Pilar de la, Ellen Weisberg, Barbara Muz, et al.. (2015). Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia. Leukemia Research. 39(11). 1299–1308. 19 indexed citations
5.
Weisberg, Ellen, Atsushi Nonami, Chen Zhao, et al.. (2014). Upregulation of IGF1R by Mutant RAS in Leukemia and Potentiation of RAS Signaling Inhibitors by Small-Molecule Inhibition of IGF1R. Clinical Cancer Research. 20(21). 5483–5495. 14 indexed citations
6.
Weisberg, Ellen, Atsushi Nonami, F. Liu, et al.. (2014). Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies. Leukemia. 29(1). 27–37. 49 indexed citations
7.
Weisberg, Ellen, Atsushi Nonami, & James D. Griffin. (2014). Combination therapy with nilotinib for drug-sensitive and drug-resistant BCR-ABL-positive leukemia and other malignancies. Archives of Toxicology. 88(12). 2233–2242. 6 indexed citations
8.
Weisberg, Ellen, Qingsong Liu, Xin Zhang, et al.. (2013). Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells. PLoS ONE. 8(2). e56473–e56473. 37 indexed citations
9.
Bhanot, Haymanti, Mamatha M. Reddy, Atsushi Nonami, et al.. (2013). Small Molecule Activators Of AMPK Block The Glycogen Production Required For Transformation Of Myeloid Leukemia Cells. Blood. 122(21). 1479–1479. 2 indexed citations
10.
Shima, Takahiro, Goichi Yoshimoto, Atsushi Nonami, et al.. (2008). Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient. International Journal of Hematology. 88(3). 336–340. 24 indexed citations
11.
Nonami, Atsushi, Katsuto Takenaka, Kenjiro Kamezaki, et al.. (2007). Successful Treatment of Primary Cardiac Lymphoma by Rituximab-CHOP and High-Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation. International Journal of Hematology. 85(3). 264–266. 28 indexed citations
12.
Nonami, Atsushi, Toshihiro Miyamoto, Megumi Kuroiwa, et al.. (2007). Successful Treatment of Primary Plasma Cell Leukaemia by Allogeneic Stem Cell Transplantation from Haploidentical Sibling. Japanese Journal of Clinical Oncology. 37(12). 969–972. 5 indexed citations
13.
Takeishi, Shoichiro, Toshihiro Miyamoto, Atsushi Nonami, et al.. (2007). Toxoplasmosis encephalitis following severe graft‐vs.‐host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. European Journal Of Haematology. 79(4). 317–321. 32 indexed citations
14.
Kamezaki, Kenjiro, Yoshikane Kikushige, Akihiko Numata, et al.. (2007). Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma. Bone Marrow Transplantation. 39(9). 523–527. 18 indexed citations
15.
Nagafuji, Koji, Atsushi Nonami, Yoshikane Kikushige, et al.. (2007). Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica. 92(7). 978–981. 82 indexed citations
16.
Taketomi, Takaharu, Daigo Yoshiga, Koji Taniguchi, et al.. (2005). Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia. Nature Neuroscience. 8(7). 855–857. 113 indexed citations
17.
Nonami, Atsushi, Takaharu Taketomi, Akiko Kimura, et al.. (2005). The Sprouty‐related protein, Spred‐1, localizes in a lipid raft/caveola and inhibits ERK activation in collaboration with caveolin‐1. Genes to Cells. 10(9). 887–895. 36 indexed citations
18.
Inoue, Hiromasa, Reiko Kato, Satoru Fukuyama, et al.. (2005). Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness. The Journal of Experimental Medicine. 201(1). 73–82. 95 indexed citations
19.
Nonami, Atsushi, Reiko Kato, Koji Taniguchi, et al.. (2004). Spred-1 Negatively Regulates Interleukin-3-mediated ERK/Mitogen-activated Protein (MAP) Kinase Activation in Hematopoietic Cells. Journal of Biological Chemistry. 279(50). 52543–52551. 75 indexed citations
20.
Okafuji, Takashi, Shuji Sakai, Kengo Yoshimitsu, et al.. (2004). Pulmonary metastasis from pancreatic cancer: a case showing biphasic radiological and histological patterns. 28(7). 68–71. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026